The isolation and structure of 13,18 dehydroglaucarubinone, a new antineoplastic quassinoid from Simarouba amara by Polonsky, J. et al.
The isolation and structure of 13,18-dehydroglaucarubinone, a new antineoplastic quassinoid from Simarouba 
amara 
Judith Polonsky, Zoïa Varon, H. Jacquemin' and G.R. Pettit2j3 
Institut de Chiwiie,des Substances Naturelles, CNRS, F-91 I90 G$-sur- Yvette (France), 19 January 1978 
Summary, An investigation of the Guyana plant Simarouba amara Aubl. (Simaroubaceae) for antineoplastic quassinoids 
led to isolation and structural determination of the new quassinoids 2'-acetylglaucarubine (la) and 13, Wdehydroglaucaru- 
binone (2). The previously known 2'-acetylglaucarubinone (3a) and glaucarubinone (3b) were also obtained. The new 
quassinoid 2 was found significantly to inhibit growth of the murine lymphocytic leukemia P388. 
Several quassinoids4, the bitter principles of the plant 
famgy Simaroubaceae, have exhibited promising anti- 
cancer a ~ t i v i t y ~ . ~  and bruceantin has recently been placed 
on clinical trial by the US National Cancer Institute6. Part 
of our earlier program, directed at uncovering new antineo- 
plastic quassinoids produced by Simaroubaceae, was 
concerned with the Guyana species Sinzarouba amara Aubl. 
Initially 5-hydroxycanthin-6-one7 and 4 A7-tirucallol-type 
triterpenes, (believed to be biogenetic precursors of the 
quassinoids4; namely oxo-3-tirucalla-7,24-diene, dioxo- 
3,21-tirucalla-7,24-diene', melianone and 21,20-anhy- 
dromelianoneg) were isolated and characterized. We report 
here the isolation, structural elucidation and preliminary 
anticancer evaluation of 2 new quassinoids designated 2'- 
acetylglaucarubine (la) and 13,18-dehydroglaucarubinone 
(2). The previously known quassinoids, T-acetylglaucarubi- 
none (3a)'O5'' and glaucarubinone (3b)"9'2, were also isolat- 
ed from Simarouba amara. Quassinoid 2 was found to show 
significant antineoplastic activity (54% life extension at 
2 mg/kg) in the National Cancer Institute's murine lympho- 
cytic leukemia P388 (PS ~ystem)'~. 
The dried, finely ground root bark of Simarouba amara was 
extracted with hexane and several times with boiling water. 
The aqueous extract was concentrated under reduced pres- 
sure and continuously extracted with chloroform. Evapora- 
tion of the chloroform yielded a bright yellow foam which 
crystallized upon addition of chloroform to give 2'-acetyl- 
glaucarubine (la) as colorless needles, m.p. 243-246 "C 
[a],+29.5" (c, 1.1, pyridine). The empirical formula 
c&3@11 (M+ at m/e 538) and similarity of the 'H-NMR- 
spectrum with that of glaucarubine (lb) suggested that this 
new quassinoid might be the a-acetoxy-a-methylbutyrate 
ester of glaucarubol (IC). The presence of such an ester was 
further indicated by fragment ions in the mass spectrum at 
d e  143 [COC(OAc)(CH,)C2H5]+,l 15 [C(OAc) (CH3)C2Hs]', 
83 [COC(CH,)=CHCH,]+ and by a strong signal at m/e 
360 corresponding to the loss of water and a-acetoxy-a- 
1 
methyl-butyric acid from the molecular ion. Furthermore, 
the '-H-NMR-spectrum displayed signals for primary, ter- 
tiary and acetate methyl groups assignable to the ester (t, 
0.98; s, 1.65 and s, 2.03 ppm, respectively) and a 1 proton 
downfield doublet at 5.48 pm (J=9 Hz) indicating the 
ester bonding to be at C-15'; the remaining signals corre- 
spond in chemical shift to those assigned gla~carubine'~. 
Structure l a  was unequivocally confirmed by acetylation 
(acetic anhydride-pyridine) which gave the pentaacetate of 
glaucarubine (4)15. The acetylation product 4 was identical 
with an authentic sample. 
The mother liquors from the 2'-acetylglaucarubine (la) 
isolation were subjected to column chromatography (Sili- 
cage1 60, E. Merck). Elution with chloroform containing 2% 
methanol afforded the known 2'-acetylglaucarubinone 
(3a)'O,'' and, on increasing to 5% methanol, yielded a 
crystalline fraction that contained glaucarubinone (3b)"3'2 
and the new antineoplastic agent 13,18-dehydroglaucarubi- 
none (2). Separation of the latter 2 quassinoids was 
achieved by repeated preparative TLC (Silicagel, 1510 LS 
254, Schleicher and Schiill, chloroform-methanol, 9: 1). 
The 13,18-dehydroglaucarubinone (2) molecular formula 
was found to be C25H32010 (M+ at m/e 492); m.p. 215- 
13C-NMR spectral assignments (CDC13/pyridine-dS solution, 
downfield from internal trimethylsilane) for 13,18-dehydroglau- 
carubinone 
83.18 C(9) 41.8 C(18) 121.7 
9.8 C(2) 196.8 
(213) 125.4 C(11) 109.1 C(30) 71.6 
C(10) 45.1 C(19) 
CU) 
c(4j 162.3 ' Cil25 79.4. 4-Me 26.7 
45.0 C(13) 141.1 C(1') 175.8 
25.3 C(14) 51.4 C(2') 75.0 
7.9 
25.8 
C(5) 
C(6) 
C(7) 
C(8) 
78.4 , C(15) 69.3 C(3') 33.1 
47.1 C(16) 166.6 C(4') c (5') . ,  
15.9.78 Specialia 1123 
2 - l a  R = COC(CH3)(OAc)CH&H3 - 
b R = COC(CH,)(OH)CHzCH3 
c R = H  
- 3a R=Ac , 
b R = H  
218 'C. [a],+ 34.7 o (c= 0.95, MeOH). The A-ring assign- 
ment for quassinoid 2 was supported by the UV-spectrum 
(A, 252 nm), the circular .dichroism, curve [(ilE+- 1.06 
(320 nm)], the 'H-NMR-data (CDC13, at 90 'MHz, vinyl 
methyl at 2.04, H-1 at 4.3 ppm and H-3 at 6.15 ppm) and by 
the characteristic16 mass spectral fragment ions at m/e 151 
and 247. The mass spectrum of quassinoid 2 also indicated 
the presence of an a-hydroxy-a-methylbutyrate ester corre- 
sponding to m/e 73 [C(OH)(CH,)C,H,]+ and m/e 83 
[COC(CH3)= CH-CH3]+. The 'H-NMR of quassinoid 2 
displayed resonances at 0.87 (t), 1.5 (s) and 1.2 (s) ppm 
assignable to the C-4', C-2' and (2-10 methyl groups. The 
absence of a signal corresponding to a C-13 methyl group 
and presence of 2 signals at 5.21 ppm in the H'-NMR- 
spectrum of substance 2 allowed assignment of the 13,18- 
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double bond. An AB quartet centred at 3.73 ppm (J= 9 Hz) 
corresponded to the -CH,O-methylene involved in the 
11,30-hemiketal. Signals at 3.13 (s), 4.07 (s), 4.62 (t) and 
5.87 (d, J= 12 Hz) were assigned to protons H-9, H-12, H-7 
and H- 15, respectively. The 13,18-dehydroglaucarubinone 
(2) structural assipment was confirmed by a 13C-NMR- 
analysis (table)I7* . 
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